Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06342284
Other study ID # NYPC ERC# 2021-030
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 22, 2024
Est. completion date March 21, 2031

Study information

Verified date March 2024
Source The New York Proton Center
Contact Nitin Ohri, MD
Phone 718-405-8550
Email nitin.ohri@einsteinmed.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.


Description:

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards. Primary Objective • To demonstrate the feasibility of patient-generated health data collection during thoracic proton beam radiotherapy for lung cancer. Secondary Objective • To demonstrate the face validity of physical activity and vital sign data collected during proton beam radiotherapy for lung cancer. Exploratory Objective • To explore associations between radiotherapy treatment parameters, wearable device data, patient-reported outcomes, adverse events, and long-term clinical outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date March 21, 2031
Est. primary completion date March 21, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Plan for fractionated (=15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer - Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted. - Concurrent chemotherapy is permitted but not required.. - Previous thoracic radiotherapy is allowed. - Ability to complete study surveys in English or Spanish - Age >/= 18 - Concurrent enrollment on other trials is permitted - Patients who already use wearable devices and/or smartphones that monitor physical activity are eligible for this trial, provided they agree to utilize the devices provided by the study team during the study period - All patients must sign study-specific informed consent prior to study entry Exclusion Criteria: - Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy - Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Proton Beam Radiation with or without concurrent chemotherapy
Curative-intent fractionated proton beam thoracic radiotherapy, with or without concurrent chemotherapy

Locations

Country Name City State
United States New York Proton Center New York New York

Sponsors (1)

Lead Sponsor Collaborator
The New York Proton Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Assess associations between radiotherapy treatment parameters, wearable device data, patient-reported outcomes, adverse events, and long-term clinical outcomes using inferential statistical analyses. Inferential statistical analyses carried out in support of this objective will be exploratory, recognizing the feasibility nature of the study, the associated lack of statistical power, and that these analyses are intended to estimate effect sizes to inform future studies. 5 Years
Primary Demonstrate the feasibility of patient-generated health data collection during thoracic proton beam radiotherapy for lung cancer, based on the quantity of data collected from the day of radiotherapy initiation to the day of radiotherapy completion. Feasibility assessed based on the quantity of data collected from day of radiotherapy initiation to day of radiotherapy completion. The feasibility of physical activity data collection will be assessed based on usage information provided by the Apple Watch. Descriptive statistics to be used to report the distribution of average use times in the study cohort and the proportion of days subjects wear the Apple Watch for at least 8 hours. The feasibility of daily home pulse oximeter data collection reported using frequencies and percentages. The feasibility of weekly electronic PRO collection reported using frequencies and percentages. 4-5 Weeks
Secondary Demonstrate the face validity of physical activity and vital sign data collected in this trial by reviewing the distribution of values obtained for each measure quantitatively using descriptive statistics. Face validity will be evaluated by reviewing the distribution of values obtained for each measure quantitatively using descriptive statistics (mean, standard deviation, median, range) and visually using histograms and boxplots. Additionally, the proportion of reported measures outside of the expected range based on subjects' medical conditions and data obtained during clinic visits (i.e., non-physiologic outliers) will be estimated by the study team. Data elements will be deemed to have face validity if less than 5% of the collected values fall outside the expected range. 4-5 Weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04837950 - Changes in Pleural Cavity Volume and Surgical Exposure N/A
Completed NCT03121287 - Early Imaging Biomarkers in NSCLC
Completed NCT04553471 - Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers N/A
Recruiting NCT05053230 - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer N/A
Completed NCT04570722 - Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study) N/A
Completed NCT05459311 - Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)
Completed NCT01833637 - Electronic Patient Reported Symptom Assessment N/A
Completed NCT03676426 - Comparison of a Web-based Advance Directive to a Standard Advance Directive N/A
Completed NCT03658083 - Exploring Robotic-assisted Thoracic Surgery for Lung Cancer
Recruiting NCT05063396 - OFA in Thoracic Surgery N/A
Recruiting NCT03804307 - Short Course Radiation Therapy in Palliative Treatment of Thoracic Cancer N/A
Enrolling by invitation NCT05629065 - Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) N/A
Recruiting NCT04749212 - Perioperative Troponin I and NT Pro-BNP in Lung Resection
Recruiting NCT05502263 - Interest of CPET to Predict Mortality and Complications of Lung Resection Candidates
Recruiting NCT05351268 - 3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors N/A
Recruiting NCT05349552 - Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
Recruiting NCT05549414 - Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System N/A
Recruiting NCT04799561 - Teleprehabilitation for Surgical Cancer Patients N/A
Completed NCT05143541 - Use of a New Stapling Device in General Thoracic Surgery
Active, not recruiting NCT04686500 - VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors N/A